Study: COVID-19 vaccine effectiveness may wane in younger children as well

Feb 17, 2023 - 04:02 PM

Completing the Moderna or Pfizer COVID-19 monovalent vaccine primary series protects children aged 3-5 and 3-4, respectively, against symptomatic SARS-CoV-2 infection for at least four months, according to a study in those ages released yesterday by the Centers for Disease Control and Prevention. CDC said the data suggest the vaccines’ effectiveness may wane after 3-4 months in this age group, similar to patterns seen in older children and adults. 

According to two other studies released yesterday by CDC, only 5% of eligible children had completed a COVID-19 primary series as of Dec. 31, and only 27% of adults and 19% of adolescents had received a bivalent booster. An additional 39% of adults and 52% of adolescents’ parents were open to booster vaccination.  

CDC recommends all Americans aged 6 months and older stay up to date with the recommended COVID-19 vaccines for their age group.  

Related News Articles

Headline
View the AHA's latest United Against the Flu toolkit celebrating fall
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
CDC recommends two doses of COVID-19 vaccine for older individuals, lowers pneumococcal vaccine age 
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
CDC reminds hospital and health system workers to protect themselves, patients during respiratory virus season
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Chair File: The Best Defense Against Flu and COVID-19
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
Survey: Less than 20% of U.S. adults concerned for themselves or family receiving infection ahead of respiratory virus season
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…
Headline
FDA authorizes combination tests for flu, COVID-19
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…